88.70EUR-2.10%Mkt Cap: 849.32M EURP/E: 40.32Last update: 2026-06-01
Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internati…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap849.32M EUR
Enterprise Value859.85M EUR
Revenue (TTM)138.73M EUR
Gross Profit102.87M EUR
Net Income (TTM)20.00M EUR
Revenue/Share14.52 EUR
Last Price88.70 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees128
CountryIT
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINIT0005274094
Valuation
P/E (Trailing)40.32
P/E (Forward)29.57
PEG—
EV/EBITDA25.98
EV/Revenue6.20
P/S6.25
P/B11.68
EPS (TTM)2.20
EPS (Forward)3.06
52W Range
38.7595% of range91.50
52W High91.50 EUR
52W Low38.75 EUR
Profitability
Gross Margin77.38%
Oper. Margin15.76%
EBITDA Margin23.85%
Profit Margin15.05%
ROE28.03%
ROA15.97%
Growth
Revenue Growth24.50%
Earnings Growth44.00%
Cash Flow & Leverage
Operating CF19.56M EUR
CapEx (TTM)3.13M EUR
FCF Margin10.49%
FCF Yield1.71%
Net Debt-9.91M EUR
Net Debt/EBITDA-0.30
Balance Sheet
Debt/Equity0.29
Current Ratio2.38
Quick Ratio2.11
Book Value/Sh7.758 EUR
Cash/Share3.021 EUR
Dividends
Fwd Div Rate1.200 EUR
Trail. Div Rate0.0000 EUR
Div. Yield1.34%
5Y Avg Yield1.44%
Payout Ratio45.45%
Ex-Div DateMay 4, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)81.33 EUR
Target Range76.00 EUR – 86.00 EUR
# Analysts3
Ownership
Shares Out.9.58M
Float3.28M
Insiders65.02%
Institutions16.65%
Technical
SMA 5080.76 (+9.8%)
SMA 20060.80 (+45.9%)
Beta0.10
S&P 52W Chg27.94%
Avg Vol (30d)12.98K
Avg Vol (10d)9.45K
Technical Indicators
RSI (14)68.0
MACD2.4614
MACD Signal2.3936
MACD Hist.+0.0678
BB Upper94.97 EUR
BB Middle84.86 EUR
BB Lower74.75 EUR
BB Width23.83%
ATR (14)2.870 EUR
Vol Ratio (20d)1.16x